Here's What Trump Did After That Pharma Executive Collapsed in the Oval Office
Supreme Court Issues Emergency Order Temporarily Blocking Full SNAP Payments
A Century Later, Some Haven't Learned History's Lessons on Communism
Video From Condé Nast Shows It Is Like a Daycare Center for Journos...
Maine Voters OK Red Flag Law Because Experts Blew It
100-Year-Old WWII Veteran Says the Sacrifices of His Generation Were Not Worth It
The Evil Unleashed in 2008: From Obama, to Biden, to Harris, to Mamdani
Surrender, But Don't Give Yourself Away
A Veterans Day Call to Restore the Warrior Corps
Bringing Back Hemp Prohibition Would Be a Massive Mistake
Congress Shouldn’t Bury a Hemp Ban in a Bill to Feed Families and...
Federal Judge Blocks Trump From Sending Troops to Portland
Trump Orders DOJ to Investigate Foreign Meat-Packing Companies Over Price-Fixing
US Strikes Deal to Restore Funding to Cornell University
38 Charged Following Investigations by the Nashville Homeland Security Task Force
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos